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The function of the Rex protein of human T-cell leukemia virus type I (HTLV-I) has been demonstrated to be very similar
to the Rev protein of human immunodeficiency virus type 1 (HIV-1). Both of these retroviral regulatory proteins rescue
unspliced viral RNAs from the nuclei of infected cells. The Rev protein of HIV-1 has been reported to shuttle between the
nucleus/nucleolus and the cytoplasm. Here, we have found that Rex also relocated out of the nucleus in the presence of
actinomycin D. This effect was demonstrated in dose- and time-course-dependent manners. In comparison with previous
reports on HIV-1 Rev, these effects with Rex seemed to be similar, but less distinct, which may reflect precise differences
in the subcellular localization and/or shuttling pathways of Rev and Rex. Interestingly, the endogenous truncated form of
the Rex protein, p21x, significantly interfered with the intracellular translocation of Rex, when coexpressed in trans. As
expression of p21x occurs in various HTLV-I-infected cells, p21x may play a role in the life-cycle of HTLV-I, through regulating
the dynamic subcellular distribution of the viral trans-activator, Rex. q 1996 Academic Press, Inc.
The Rex protein of human T-cell leukemia virus type I tribution of Rex in the presence of actinomycin D, which
is known to interfere with nuclear translocation of pro-(HTLV-I) has been regarded as a functional equivalent
to the Rev protein of human immunodeficiency virus type teins by inhibiting RNA polymerase activity (22). We also
evaluated the effect of the HTLV-I p21x protein on the1 (HIV-1). These proteins have been shown to be local-
ized predominantly within nuclei, particularly cell nucleoli subcellular distribution of the Rex protein.
The p21x protein can be defined as a natural truncated(15, 25), possess their own nucleolar targeting signals
(NOS) (12, 25), and are responsible for the cytoplasmic form of Rex. The initiation methionine of p21x corre-
sponds to the 79th residue of Rex (Fig. 1). Although theexpression of viral structural and enzymatic proteins. Pro-
duction of these viral proteins are enabled by the cyto- function(s) of p21x remains unknown, the expression of
p21x was confirmed and p21x-specific mRNAs were iden-plasmic accumulation of their unspliced or partially
spliced mRNAs, mediated by the direct interaction of Rex tified in a variety of HTLV-I-infected cell-lines and in pri-
mary uncultured cells from adult T-cell leukemia (ATL)or Rev and the secondary-structured target on their
mRNA called the Rex-responsive element (RxRE), or Rev- patients (2, 8, 21). Here, based on the results obtained
in this study, a possible role for p21x in the life-cycle ofresponsive element (RRE), respectively (9, 14, 24, 28).
Further investigations have been performed primarily HTLV-I is suggested.
Two eukaryotic expression plasmids have been con-for the Rev protein. The major function of Rev was shown
to be the export of RRE-containing RNA (7). Subsequently, structed to obtain independent expression of Rex and
p21 (Fig. 1). Since the p21x gene is a part of the rex gene,several groups have reported, independently, that Rev
shuttles between the cytoplasm and nucleus (5, 6, 11, we had to introduce a point mutation at the initiation
codon of the p21x gene to avoid concomitant expression17, 23, 27). However, few reports regarding intracellular
shuttling have been presented on Rex (26). Using two of p21x along with the Rex protein. The Rex expression
plasmid, pH2RexdL, produces a Rex protein with an iso-antisera, which recognize the N-terminus and C-terminus
of the Rex protein, we analyzed the distribution and redis- leucine residue at residue number 79, instead of methio-
nine, which had been proven to be fully functional (12).
Construction of these plasmids was previously described1 Present address: Shionogi Institute for Medical Science, Settsu-
(12, 19). They possess the same backbone, with an SV40shi, Osaka, 566, Japan.
promoter and origin of replication (Fig. 1). The experi-2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (215) 923-1956. ments were performed by transient gene expression and
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FIG. 1. Primary structures of the Rex-constructs. pKCR21X and pH2RexdL represent eukaryotic expression vectors which express the respective
proteins illustrated. The structure of wild-type Rex is shown for comparison. Four amino acid sequences from initiation methionines of Rex and
p21x are displayed as single letter codes. The alternative isoleucine residue in pH2RexdL, which had been introduced by site-directed mutagenesis,
is shown in an outlined letter. Numbers denote residues counted from the initiation methionine of the Rex protein. Amino acid sequence-numbers
of the synthetic peptides, used for raising each antibody against Rex, are also indicated at the bottom of the figure.
subsequent immunofluorescence analyses. Cos-1 cells both antibodies and obtained very similar results (Fig.
3), suggesting the significance and specificity of thesewere maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum results. Of note, the effects observed were somewhat
less dramatic than for similar experiments with HIV-1(FBS). Twenty hours prior to DNA transfection, cells were
seeded into 8-well Lab-Tek Chamber slides (Nunc, Inc.) Rev (23).
Then, we performed time-course studies at a fixedat a cell density of 5 1 104/well. For each well, 250 ng
of pH2RexdL with or without 250 ng of pKCR21X was concentration of actinomycin D, and also elucidated the
dose-dependency of these effects. The demonstrationtransfected by an established DEAE-dextran method with
slight modifications (4). Forty-eight hours after transfec- of the nuclear-export of Rex, which was manifested by
actinomycin D at a concentration of 10 mg/ml, graduallytion, cells were treated with 10 mg/ml of cycloheximide
and various concentrations of actinomycin D or 100 mM rose as the incubation time increased until 3.5 hr. How-
ever, Rex did not seem to be completely exported outof 5,6-dichlororibosyl benzimidazole (DRB) for 1 to 3.5 hr
at 377. Afterwards, cells were washed with phosphate- of the nuclei even after 3.5 hr (Fig. 4A). In a series of
experiments performed with a fixed incubation time of 2buffered saline (PBS), fixed with 3.5% formaldehyde/PBS
for 20 min, and permeablized with 0.1% NP-40/PBS for hr, as the concentration of actinomycin D was decreased,
the nuclear-export of Rex was also remarkably attenu-10 min at room temperature. Two affinity-purified immu-
noglobulin G (IgG) fractions of rabbit anti-Rex sera were ated in a dose-dependent manner (Fig. 4B). In fact, at a
concentration of 0.1 mg/ml, actinomycin D demonstratedused for detection of intracellular Rex or p21x. The anti-
bodies, which were designated as anti-RexN and anti- only slight effects on the intracellular redistribution of
Rex. These findings are similar, but somewhat differentRexC, had been raised against synthetic peptides corre-
sponding to residues 1– 22, and residues 175 – 189 of from published data on the HIV-1 Rev protein, in which
Rev was expelled out of the nucleus, in most cells, afterthe Rex protein, respectively. Therefore, anti-RexN reacts
only with Rex, whereas anti-RexC reacts with both Rex incubation with 0.04 mg/ml of actinomycin D (23). The
effect of 100 mM of DRB, which had been shown to specif-and p21x, as confirmed by radioimmunoprecipitation
analysis in a previous report (1). ically inhibit RNA polymerase II activity (22), was also
evaluated and was comparable to 0.1 mg/ml actinomycinIn initial experiments, we analyzed the subcellular dis-
tribution of the Rex protein in the absence or presence D (data not illustrated). At the present stage, it is not
possible to clearly dissect the relationship between intra-of actinomycin D at a relatively high dose, while transla-
tion was arrested by cycloheximide. As shown in Figs. 2 cellular translocation of Rex and specific RNA polymer-
ase activities. High doses of actinomycin D, such as 10and 3, treatment with 10 mg of actinomycin D for 2 hr
dramatically altered the subcellular distribution of Rex. mg/ml, and DRB may cause nucleolar disintegration (5,
6), and may affect other biological functions of the cell.The nuclear-dominant population decreased and cyto-
plasmic-dominant cellular population increased with ac- Further investigation is required to determine which cel-
lular factor(s) is responsible for the nuclear export of thetinomycin D. Thus, Rex is found to migrate out from the
cell nucleus. We repeated the same experiment using Rex protein.
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FIG. 2. Representative photomicrographs of the intracellular distribution of Rex with or without actinomycin D treatment. Cos-1 cells were
transfected with pH2RexdL, incubated in culture media containing 10 mg/ml of cycloheximide (Cyclo) with or without 10 mg/ml of actinomycin D
(Ac. D) for 2 hr at 377, and stained with either anti-RexN or anti-RexC antibody. (Top) After treatment with cycloheximide only. (Bottom) Treatment
with actinomycin D and cycloheximide. (Right) Stained with anti-RexN. (Left) Stained with anti-RexC. Immunofluorescence was obtained by secondary
staining with fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit polyclonal IgG.
FIG. 3. The intracellular redistribution effects of actinomycin D on the Rex protein. Results from independent experiments, using two different
antibodies, are displayed. Cos-1 cells were transfected with pH2RexdL and the distribution pattern of Rex was analyzed by indirect immunofluores-
cence (IF). More than 50 IF-positive cells were classified into three groups, and each cellular population is represented by the following bars, as
percentages of total cells counted. Solid black bar, nuclear  cytoplasmic. Hatched bar, nuclear  cytoplasmic. Stippled bar, nuclear  cytoplasmic.
Values after 2 hr incubation with and without 10 mg/ml of actinomycin D, in the presence of cycloheximide, are compared in each panel. (A) Analyses
by anti-RexN antibody. (B) Analyses by anti-RexC antibody.
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initial experiments was employed (see Fig. 6, legend),
and total DNA quantities of each transfection experi-
ment was adjusted equally by the parental plasmid, so
as to standardize the expression level of the Rex protein.
Examination of the effect of three different doses of
the p21x0 expression construct has clearly uncovered
a dose-dependent, significant effect of p21x on the sub-
cellular redistribution of the Rex protein, in the presence
of actinomycin D (Fig. 6).
We have analyzed the subcellular distribution of the
Rex protein and found that it was translocated from the
nucleus to the cytoplasm after treatment with actinomy-
cin D. Relatively less strong nuclear export was ob-
served with Rex, at similar doses of actinomycin D, as
compared to the Rev protein of HIV-1. This may be due
to the differences in the intranuclear localization and
shuttling pathways between these two retroviral pro-
teins. Detailed analyses by confocal laser scanning mi-
croscopy had shown that Rex is present as nucleolar
speckles in an HTLV-I-infected cell-line and can be seen
diffusely in the nucleoplasm when highly expressed by
transient DNA transfection in Cos-7 cells (20). In con-
trast, Rev accumulates strongly into the nucleolus with
very little distribution in the nucleoplasm, even when it
was overexpressed (15). No Rev-speckle formation was
observed and Rev was distributed diffusely within the
nucleoli (20). These differences could be caused by dif-
FIG. 4. (A) Time-course studies of the effects of 10 mg/ml of actinomy- ferent modes of interactions between nuclear/nucleolar
cin D. Cos-1 cells transfected with pH2RexdL were analyzed after vari-
factors and Rev or Rex.able hours of incubation. (B) Dose-dependency of the effects of actino-
The Rex protein possesses two distinct domains whichmycin D on the intracellular distribution of Rex. Cells were treated with
are thought to be responsible for nucleo-cytoplasmiceach concentration of actinomycin D for 2 hr at 377 and analyzed by
indirect immunofluorescence microscopy. More than 50 IF-positive shuttling. One is the NOS (residue 1 –19), which is re-
cells, stained with anti-RexC antibody, were classified in three groups quired for the nuclear/nucleolar accumulation of Rex, and
as described in the legend of Fig. 1. Each population is represented the other is the so-called leucine-motif/activation domainas percentages of total IF-positive cells. Solid black box, nuclear 
(residue 82– 93) (16). This domain is thought to be acytoplasmic. Hatched box, nuclear cytoplasmic. Stippled box, nuclear
nuclear export signal (NES), although there has been no cytoplasmic. These data are representative of at least two indepen-
dent experiments for each variable. evidence which has clearly demonstrated that the Rex
leucine-motif/activation domain is a NES. Of note, the
peptide motif of the Rex leucine-motif/activation domain
The function of p21x remains unknown; however, a is functionally interchangeable with that of the Rev NES
possible antagonistic functional role of p21x against Rex (10) and cellular factors that bind to the Rev NES were
had been reported (8). Therefore, we suspected that shown to bind to the leucine-motif/activation domain of
p21x may alter the subcellular distribution of Rex. To Rex as well (3, 13). Interestingly, the p21x protein retains
address this hypothesis, we coexpressed p21x with Rex the putative NES at its amino terminus. However, since
in Cos-1 cells, by transient cotransfection. Since anti- p21x is lacking the NOS, it retains no function as Rex. In
RexN reacts only with Rex, we could analyze the subcel- this study, enhancement of the nuclear localization of
lular distribution of Rex in the presence of coexpressed Rex by the p21x protein was observed. A mechanism(s)
p21x using this antibody. Expression of p21x, from this to explain these effects can be proposed. Owing to the
plasmid in Cos-1 cells, was previously confirmed by putative NES, p21x would be able to bind to the cellular
immunofluorescence (IF) and radioimmunoprecipitation cofactors which are responsible for nuclear export. Such
analyses (18). As shown in Fig. 5, the p21x protein signif- binding of these factors to p21x would not assist in the
icantly enhanced the nuclear-localization of the Rex pro- export of viral RNAs. Consequently, in the presence of
tein, regardless of actinomycin D treatment. The signifi- p21x, the cellular factors which are responsible for the
cance of the effect was further demonstrated by exten- nuclear export would be consumed. In such circum-
sive analyses. Namely, in complementary experiments, stances, the efficiency of the nuclear export of Rex would
decline and, as a result, more Rex would stay in thea transfection methodology which is different from the
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FIG. 5. Effect of the p21x protein on the subcellular localization of the Rex protein. Transfected Cos-1 cells were treated with 10 mg/ml of
cycloheximide alone or with 10 mg/ml of actinomycin D for 3.5 hr at 377. IF-positive cells, detected by anti-RexN antibody, were analyzed similarly
to other experiments (see Fig. 3 legend). Independent experiments were repeated twice and the mean values are shown with error bars. (A) Without
coexpressed p21x. (B) With coexpressed p21x.
nucleus. Thus, the observed enhancing effect of the nu- lation of these mRNA levels and the level of p21x expres-
sion has also been confirmed by quantitative reverseclear accumulation of Rex may be due to the titration of
cellular factors by p21x, via their common leucine-motif/ transcriptase-polymerase chain reaction (RT-PCR) and
Western blotting (8, 21). Thus, p21x does not seem to beactivation domain.
The expression of p21x has been confirmed not only a mere unnecessary, deleted form of Rex, which is
formed by inappropriate translational initiation on Tax/in HTLV-I-infected cell-lines (8, 21), but also, importantly,
in primary uncultured ATL cells (2). Alternatively spliced Rex mRNAs, but may be an independent regulatory pro-
tein, supplied in trans, from its own mRNAs. In this study,monocistronic mRNAs only for p21x expression have
been isolated and characterized in those studies. Corre- we supplied p21x in trans, and found a repressive effect
against Rex-shuttling. Taken together with a weak inhibi-
tory effect of p21x against Rex function, which was pre-
viously described (8), these findings imply some func-
tional roles for p21x in the life-cycle of HTLV-I. It can
be hypothesized that p21x may be involved in a less
prominent, but more delicate regulation of HTLV-I gene
expression, as compared to certain other viral regulatory
proteins. As such, it may be involved in the maintenance
of the long latency period of HTLV-I-infected-individuals.
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